| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Immunology and Cell Biology, Forschungszentrum Borstel, Borstel, Germany
The G protein-coupled CXC-chemokine receptor CXCR-2 mediates activation of neutrophil effector functions in response to multiple ligands, including IL-8 and neutrophil-activating peptide 2 (NAP-2). Although CXCR-2 has been successfully cloned and expressed in several cell lines, the molecular properties of the native neutrophil-expressed receptor have remained largely undefined. Here we report on the identification and characterization of distinct CXCR-2 glycoforms and their subcellular distribution in neutrophils. Immunoprecipitation and Western blot analyses of surface-expressed receptors covalently linked to IL-8 or NAP-2 as well as in their unloaded state revealed the occurrence of a single CXCR-2 variant with an apparent size of 56 kDa. According to deglycosylation experiments surface-expressed CXCR-2 carries two N-linked 9-kDa carbohydrate moieties that are both of complex structure. In addition, two other CXCR-2 variants of 38 and 40 kDa were found to occur exclusively intracellular and to carry N-glycosylations of high mannose or hybrid type. These receptors did not participate in ligand-induced receptor trafficking, while surface-expressed CXCR-2 was internalized and re-expressed following stimulation with NAP-2. By enzymatic removal of one 9-kDa carbohydrate moiety in surface-expressed CXCR-2 we can show that neither NAP-2-induced trafficking nor signaling of the receptor is dependent on its full glycosylation. Instead, glycosylation was found to protect CXCR-2 from proteolytic attack, as even partial deglycosylation is associated with serine protease-mediated disappearance of the receptor from the neutrophil surface. Thus, although not directly involved in signaling, glycosylation appears to be required to maintain neutrophil responsiveness to CXC-chemokines during inflammation.
This article has been cited by other articles:
|
|
 |
|
  D. Frommhold, A. Ludwig, M. G. Bixel, A. Zarbock, I. Babushkina, M. Weissinger, S. Cauwenberghs, L. G. Ellies, J. D. Marth, A. G. Beck-Sickinger, et al. Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation J. Exp. Med., June 9, 2008; 205(6): 1435 - 1446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. B. Levashova, N. Sharma, O. A. Timofeeva, J. S. Dome, and A. O. Perantoni ELR+-CXC Chemokines and Their Receptors in Early Metanephric Development J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2359 - 2370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Nasser, S. K. Raghuwanshi, K. M. Malloy, P. Gangavarapu, J.-Y. Shim, K. Rajarathnam, and R. M. Richardson CXCR1 and CXCR2 Activation and Regulation: ROLE OF ASPARTATE 199 OF THE SECOND EXTRACELLULAR LOOP OF CXCR2 IN CXCL8-MEDIATED RAPID RECEPTOR INTERNALIZATION J. Biol. Chem., March 2, 2007; 282(9): 6906 - 6915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Moreno, G. Pereira-da-Silva, C. Oliver, M. C. Jamur, A. Panunto-Castelo, and M. C. Roque-Barreira The Macrophage-derived Lectin, MNCF, Activates Neutrophil Migration through a Pertussis Toxin-sensitive Pathway J. Histochem. Cytochem., June 1, 2005; 53(6): 715 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Murphy, M. McGurk, J. Pettigrew, A. Santinelli, R. Mazzucchelli, P. G. Johnston, R. Montironi, and D. J.J. Waugh Nonapical and Cytoplasmic Expression of Interleukin-8, CXCR1, and CXCR2 Correlates with Cell Proliferation and Microvessel Density in Prostate Cancer Clin. Cancer Res., June 1, 2005; 11(11): 4117 - 4127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. de Salamanca, K. F. Siemasko, Y. Diebold, M. Calonge, J. Gao, M. Juarez-Campo, and M. E. Stern Expression of Muscarinic and Adrenergic Receptors in Normal Human Conjunctival Epithelium Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 504 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Paulsen, M. M. Rosenkilde, J. Eugen-Olsen, and T. N. Kledal Epstein-Barr Virus-Encoded BILF1 Is a Constitutively Active G Protein-Coupled Receptor J. Virol., January 1, 2005; 79(1): 536 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hiruma, A. Togayachi, K. Okamura, T. Sato, N. Kikuchi, Y.-D. Kwon, A. Nakamura, K. Fujimura, M. Gotoh, K. Tachibana, et al. A Novel Human {beta}1,3-N-Acetylgalactosaminyltransferase That Synthesizes a Unique Carbohydrate Structure, GalNAc{beta}1-3GlcNAc J. Biol. Chem., April 2, 2004; 279(14): 14087 - 14095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-S. Bae, J. C. Park, R. He, R. D. Ye, J.-Y. Kwak, P.-G. Suh, and S. Ho Ryu Differential Signaling of Formyl Peptide Receptor-Like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or Lipoxin A4 in Human Neutrophils Mol. Pharmacol., September 1, 2003; 64(3): 721 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bannert, S. Craig, M. Farzan, D. Sogah, N. V. Santo, H. Choe, and J. Sodroski Sialylated O-Glycans and Sulfated Tyrosines in the NH2-Terminal Domain of CC Chemokine Receptor 5 Contribute to High Affinity Binding of Chemokines J. Exp. Med., December 3, 2001; 194(11): 1661 - 1674. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
